Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy
NCT00711061 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2009-02-10
Summary
The purpose of this study is to compare the cardiovascular risks of growth hormone deficient young adult males who have completed growth hormone therapy to healthy young adult males.
Conditions
- Growth Hormone Deficiency
Sponsors & Collaborators
-
Genentech, Inc.
collaborator INDUSTRY -
Children's Mercy Hospital Kansas City
lead OTHER
Principal Investigators
-
Carol Huseman, MD · Children's Mercy Hospital Kansas City
Eligibility
- Min Age
- 18 Years
- Max Age
- 25 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-06-30
- Primary Completion
- 2009-02-28
- Completion
- 2009-02-28
Countries
- United States
Study Locations
More Related Trials
-
Growth Hormone Deficiency in Chronic Heart Failure: A Preliminary Trial
NCT00591760 ·Status: COMPLETED ·Phase: PHASE2
-
Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women
NCT00136032 ·Status: COMPLETED ·Phase: NA
-
Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas
NCT00646308 ·Status: TERMINATED
-
Growth Hormone's Effect on the Cardiovascular System
NCT00397319 ·Status: TERMINATED
-
Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing
NCT00324064 ·Status: COMPLETED ·Phase: NA
-
Consequence of Lifetime Isolated Growth Hormone Deficiency
NCT00149708 ·Status: COMPLETED ·Phase: NA
-
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
NCT00493961 ·Status: COMPLETED ·Phase: PHASE1
-
Adult Growth Hormone Deficiency and Cardiovascular Risk
NCT00720902 ·Status: TERMINATED ·Phase: PHASE4
-
Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors
NCT00684957 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Growth Hormone and Endothelial Function in Children
NCT00373386 ·Status: COMPLETED ·Phase: PHASE4
-
Growth Hormone in a Patient With a Dominant-Negative GHR Mutation
NCT05382637 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury
NCT00638053 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With Advanced Heart Failure
NCT00182169 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of GHD Associated With CHF
NCT03775993 ·Status: UNKNOWN ·Phase: PHASE3
-
Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia
NCT01807364 ·Status: COMPLETED
-
Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
NCT00187993 ·Status: UNKNOWN
-
Effects of Growth Hormone Supplementation to Adults With Growth Hormone Deficient on Metabolism and Adipose Tissue Molecular Phenotype
NCT01616095 ·Status: COMPLETED
-
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
NCT00163189 ·Status: COMPLETED ·Phase: PHASE3
-
Growth Hormone in Ischemic Heart Failure
NCT04420481 ·Status: COMPLETED ·Phase: PHASE3
-
Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents
NCT00156143 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy
NCT00174187 ·Status: TERMINATED ·Phase: PHASE3
-
Long-Term Efficacy and Safety of Growth Hormone Replacement Therapy in Chronic Heart Failure
NCT01576861 ·Status: COMPLETED ·Phase: PHASE2
-
Growth Hormone, Cardiovascular Risk, and Visceral Adiposity
NCT00131378 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency
NCT00490191 ·Status: COMPLETED ·Phase: PHASE4
-
A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Study (FE 999905 CS07) of Zomacton in Children With Growth Hormone Deficiency
NCT02173821 ·Status: COMPLETED ·Phase: PHASE3